CSF1R and glioblastoma: Recently, we could show the establishment of PDM from human glioblastoma tissue specimen containing important components of the tumor stroma (e.g., tumor-associated macrophages), and their application for the assessment of responses towards CSF1R- and PD1-targeting antibodies as well as the small molecule inhibitor Argyrin F [44,45].